Helport AI is expanding its autonomous AI labor deployment in a Southeast Asian fintech client, targeting 300 AI workforce units by November 2026. This shift from AI-assisted human operations to fully autonomous AI aims to improve efficiency, reduce labor costs, and increase profit margins. The company’s AI systems have shown promising results in debt-collection tasks, outperforming human teams in some areas. Helport AI plans to continue scaling this model with existing and new customers, leveraging its proprietary technology platforms to support autonomous workflows and operational optimization.
Helport AI's expansion in autonomous AI labor in Southeast Asia is presented here alongside Pluang's Technology-sector snapshot as of Nov 04, 2026 05:21 WIB. Of 150 priced Technology-sector US stocks on Pluang, 97 rose and 52 fell today. Notably, CRDO and NBIS both advanced over 10% with CRDO at USD 154.68 and NBIS at USD 155.83, while SMCI also gained 10.18% at USD 33.54, contrasting their typical hold times ranging from 21 to 27 days and varying Pluang order activity favoring buys for NBIS and SMCI but sells for CRDO.
Nova Klúbburinn hf. has completed a share buyback program, acquiring 122,699,386 shares at an average price of ISK 3.26 per share. The buyback was part of an inverse offer process with valid bids for 159,526,476 shares. The company accepted bids up t...
Anthropic announced FlashProve, an open-source system designed to cryptographically verify which AI model produced a given output. This system provides a mathematical proof that an answer truly comes from a claimed model, helping prevent impersonatio...
Pomerantz LLP is investigating Concentrix Corporation and its officers for potential securities fraud following the company's lowered revenue forecasts and a $1.05 billion goodwill impairment disclosed in 2026. The stock price dropped significantly a...
Pomerantz LLP is investigating argenx SE for potential securities fraud following the company's announcement to discontinue its Phase 3 UNITY study of efgartigimod SC in moderate-to-severe Sjögren's disease due to futility. The study's halt caused ar...
Stevanato Group's shares fell sharply after its third-quarter report showed an 8% revenue increase but lowered 2027 volume expectations for its GLP-1 portfolio. The company warned of slower growth than previously anticipated, prompting concerns among...
